New Warning For Suicide Risk With Strattera
The FDA recently required Eli Lilly and Co. to include warnings for risk of suicide and suicide ideation. Strattera is prescribed to children, adolescents and adults suffering from Attention Deficit Hyperactivity Disorder (ADHD). The warning is directed at children and adolescents on the drug, especially within the first few months of going on the drug.
Post A Comment / Question